Search results for "Anticoagulation"

Results 31 - 40 of about 575 for "Anticoagulation".
Sort by: Relevance | Newest | Oldest

Latest research, recommendations cover diabetes, clots, and remdesivir in COVID-19

Mortality was lower in diabetes patients given sitagliptin at admission for COVID-19, ACP practice points support remdesivir, acquired thrombophilia does not predict clots, cardiac arrest survival is low, and admissions for other conditions were still way down over the summer.
7 Oct 2020

New guidelines cover VTE prophylaxis, diagnosis, anticoagulation, and HIT

Several guidelines related to venous thromboembolism (VTE) prevention and treatment were recently published by the American Society of Hematology, with more promised soon.
5 Dec 2018

COVID-19 research focuses on steroids, clots, hydroxychloroquine, zinc

Steroids' effects varied by C-reactive protein level, clots occurred despite prophylaxis, and hydroxychloroquine and zinc were ineffective for COVID-19, according to newly published studies.
29 Jul 2020

Updated guidelines released on antithrombotic therapy for afib

The American College of Chest Physicians provided 60 recommendation statements in the areas of stroke risk, bleeding risk, antithrombotic therapy, and management of bleeding on oral anticoagulation, among other topics.
29 Aug 2018

The puzzle of submassive PE

Treating the middle of the pulmonary embolism spectrum can be tricky.
15 Jun 2020

Pneumonia therapies, hospital flu spread, and more

Research summaries from ACP Hospitalist Weekly.
15 Aug 2020

Apixaban linked to lower risk of serious bleeding compared to warfarin in patients with or without afib

A comparison of direct oral anticoagulants and warfarin found that apixaban had the lowest number needed to treat to avoid one extra major bleed compared to warfarin, while rivaroxaban had the lowest number needed to harm with death from bleeding.
11 Jul 2018

MKSAP quiz on pulmonary embolism

This month's quiz includes questions from ACP's Medical Knowledge Self-Assessment Program (MKSAP 18) on pulmonary embolism.
15 Jun 2020

DOACs more effective, cost-effective than LMWH for cancer-associated thrombosis

A meta-analysis compared the direct oral anticoagulants (DOACs) apixaban, edoxaban, and rivaroxaban to low-molecular-weight heparin (LMWH) and found that apixaban was usually the most cost-effective option, but that finding hinged on the specific drug price.
4 Jan 2023

Frail elderly, Enterobacteriaceae infections, and more

Summaries from ACP Hospitalist Weekly.
15 Mar 2018

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next